 effect gastrin receptor antagonist proglumid surviv gastric carcinoma gastric cancer diseas poor prognosi safe effect form therapi advanc diseas evid abund gastrin growth gastric colorect cancer cell vitro vivo blockad gastrin receptor surviv xenograft nude mice studi gastrin/cholecystokinin receptor antagonist proglumid therapi patient gastric carcinoma proglumid overal effect surviv mantel-cox statist confid interv proglumid group day day control group signific differ proglumid low affin gastrin receptor partial agonist activ drug specif potent gastrin receptor antagonist avail effect surviv clinic trial compound efficaci hormon control gastrointestin malign